WHO Contraception tool

Feb 26, 2020

This update of the Medical eligibility criteria for contraceptive use provides new recommendations for women who are at high risk of HIV. WHO revised its recommendations for progestogen-only injectables and IUDs based upon new epidemiological evidence, which found no difference in HIV acquisition among women using intramuscular depot medroxyprogesterone acetate (DMPA-IM), copper intrauterine device (Cu-IUD), and levonorgestrel (LNG) implants.